EG17859A - Process for preparing of spiro-imidazolines as aldose reductase inhibitors - Google Patents
Process for preparing of spiro-imidazolines as aldose reductase inhibitorsInfo
- Publication number
- EG17859A EG17859A EG317/86A EG31786A EG17859A EG 17859 A EG17859 A EG 17859A EG 317/86 A EG317/86 A EG 317/86A EG 31786 A EG31786 A EG 31786A EG 17859 A EG17859 A EG 17859A
- Authority
- EG
- Egypt
- Prior art keywords
- spiro
- imidazolines
- preparing
- reductase inhibitors
- aldose reductase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/738,924 US4575507A (en) | 1985-05-29 | 1985-05-29 | Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use |
Publications (1)
Publication Number | Publication Date |
---|---|
EG17859A true EG17859A (en) | 1991-11-30 |
Family
ID=24970055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EG317/86A EG17859A (en) | 1985-05-29 | 1986-05-28 | Process for preparing of spiro-imidazolines as aldose reductase inhibitors |
Country Status (21)
Country | Link |
---|---|
US (1) | US4575507A (de) |
EP (1) | EP0203791B1 (de) |
JP (1) | JPS61277671A (de) |
KR (1) | KR890001548B1 (de) |
AT (1) | ATE46332T1 (de) |
AU (1) | AU560429B2 (de) |
DD (5) | DD264215A5 (de) |
DE (1) | DE3665584D1 (de) |
DK (1) | DK248886A (de) |
EG (1) | EG17859A (de) |
ES (2) | ES8800228A1 (de) |
FI (1) | FI862251A (de) |
GR (1) | GR861388B (de) |
HU (4) | HU196060B (de) |
IL (1) | IL78954A (de) |
NO (1) | NO862123L (de) |
NZ (1) | NZ216334A (de) |
PH (1) | PH22213A (de) |
PL (5) | PL147398B1 (de) |
PT (1) | PT82650B (de) |
ZA (1) | ZA863934B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4680306A (en) * | 1984-07-20 | 1987-07-14 | Pfizer Inc. | Sprio-imidazolones for treatment of diabetes complications |
US4762839A (en) * | 1985-06-06 | 1988-08-09 | Tanabe Seiyaku Co., Ltd. | Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications |
JPS63132889A (ja) * | 1986-11-21 | 1988-06-04 | Tanabe Seiyaku Co Ltd | キナゾリノン誘導体 |
EP0306525A4 (en) * | 1987-03-20 | 1991-04-24 | Alcon Laboratories Inc | Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes mellitus |
US5004751A (en) * | 1987-08-28 | 1991-04-02 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
US5202339A (en) * | 1987-08-28 | 1993-04-13 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
AU623676B2 (en) * | 1988-08-24 | 1992-05-21 | Mochida Pharmaceutical Co., Ltd. | Hydantoin derivatives |
US5068332A (en) * | 1990-10-12 | 1991-11-26 | American Home Products Corporation | Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors |
US8326636B2 (en) * | 2008-01-16 | 2012-12-04 | Canyon Ip Holdings Llc | Using a physical phenomenon detector to control operation of a speech recognition engine |
JP6105631B2 (ja) * | 2012-02-09 | 2017-03-29 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 1,4−保護9−ヒドロキシ−5−オキソ−1,4−ジアザ−スピロ[5.5]ウンデカンの立体選択的合成方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1088945A (en) * | 1976-10-18 | 1980-11-04 | Pfizer Limited | Hydantoin derivatives as therapeutic agents |
US4117230A (en) | 1976-10-18 | 1978-09-26 | Pfizer Inc. | Hydantoin derivatives as therapeutic agents |
US4235911A (en) * | 1979-06-13 | 1980-11-25 | Pfizer Inc. | Hydantoin derivatives |
US4248882A (en) * | 1980-02-12 | 1981-02-03 | Pfizer Inc. | Treating diabetes-associated complications with hydantoin amines |
JPS5745185A (en) * | 1980-07-21 | 1982-03-13 | Eisai Co Ltd | Hydantoin derivative and its preparation |
ATE23046T1 (de) * | 1982-11-10 | 1986-11-15 | Pfizer | Sorbinil durch optische aufspaltung mit aminopinanderivaten. |
US4556670A (en) | 1982-12-06 | 1985-12-03 | Pfizer Inc. | Spiro-3-hetero-azolones for treatment of diabetic complications |
ZA839023B (en) * | 1982-12-06 | 1985-07-31 | Pfizer | Spiro-3-hetero-azolones for treatment of diabetic complications |
EP0159143B1 (de) * | 1984-03-23 | 1987-12-16 | Pfizer Inc. | Spiro-Indene und Spiro-1,2-Dihydro-Naphthalene für die Behandlung von diabetischen Komplikationen |
US4762838A (en) | 1985-08-30 | 1988-08-09 | Pfizer Inc. | Quinazolin-4(3H)-one derivatives as anticoccidial agents |
-
1985
- 1985-05-29 US US06/738,924 patent/US4575507A/en not_active Expired - Lifetime
-
1986
- 1986-05-23 DE DE8686303925T patent/DE3665584D1/de not_active Expired
- 1986-05-23 AT AT86303925T patent/ATE46332T1/de not_active IP Right Cessation
- 1986-05-23 EP EP86303925A patent/EP0203791B1/de not_active Expired
- 1986-05-27 PL PL1986266364A patent/PL147398B1/pl unknown
- 1986-05-27 ES ES555375A patent/ES8800228A1/es not_active Expired
- 1986-05-27 DD DD86309080A patent/DD264215A5/de not_active IP Right Cessation
- 1986-05-27 DD DD86309078A patent/DD264213A5/de not_active IP Right Cessation
- 1986-05-27 DD DD86309079A patent/DD264214A5/de not_active IP Right Cessation
- 1986-05-27 PT PT82650A patent/PT82650B/pt not_active IP Right Cessation
- 1986-05-27 PL PL1986266365A patent/PL147399B1/pl unknown
- 1986-05-27 ZA ZA863934A patent/ZA863934B/xx unknown
- 1986-05-27 PL PL1986266366A patent/PL147400B1/pl unknown
- 1986-05-27 PL PL1986259739A patent/PL146020B1/pl unknown
- 1986-05-27 DD DD86290626A patent/DD251972A5/de not_active IP Right Cessation
- 1986-05-27 PL PL1986266363A patent/PL147397B1/pl unknown
- 1986-05-28 EG EG317/86A patent/EG17859A/xx active
- 1986-05-28 KR KR8604182A patent/KR890001548B1/ko not_active IP Right Cessation
- 1986-05-28 HU HU862249A patent/HU196060B/hu unknown
- 1986-05-28 NZ NZ216334A patent/NZ216334A/xx unknown
- 1986-05-28 HU HU893124A patent/HU199845B/hu unknown
- 1986-05-28 DK DK248886A patent/DK248886A/da not_active Application Discontinuation
- 1986-05-28 GR GR861388A patent/GR861388B/el unknown
- 1986-05-28 AU AU58012/86A patent/AU560429B2/en not_active Ceased
- 1986-05-28 FI FI862251A patent/FI862251A/fi not_active Application Discontinuation
- 1986-05-28 NO NO862123A patent/NO862123L/no unknown
- 1986-05-28 HU HU872418A patent/HUT49879A/hu unknown
- 1986-05-28 IL IL78954A patent/IL78954A/xx unknown
- 1986-05-29 PH PH33830A patent/PH22213A/en unknown
- 1986-05-29 JP JP61124608A patent/JPS61277671A/ja active Pending
-
1987
- 1987-02-13 ES ES557391A patent/ES8801830A1/es not_active Expired
- 1987-05-28 HU HU893127A patent/HU893127D0/hu unknown
- 1987-11-16 DD DD87309077A patent/DD273258A5/de not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1260471C (de) | ||
PH22520A (en) | Heterocyclic compounds having 4-lover alkyl-3-hydroxy-2-lower alkyl phenoxy-lower alkylene-y-group, and process of producing them | |
EG17859A (en) | Process for preparing of spiro-imidazolines as aldose reductase inhibitors | |
AU2868689A (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
PH24139A (en) | Method of treating anxiety with tetrahydrobenzy(c,d)indole-6-carboxamides | |
AU6216886A (en) | Substituted 2-cyano-2-phenyl ethyl-amine | |
HUT46043A (en) | Process for producing immunstimulant acyltripeptides | |
GR3019893T3 (en) | Novel S-adenosyl methionine decarboxylase inhibitors | |
HUT46214A (en) | Process for producing medical preparation suitable for treatment of peptic ulcer | |
DE3167347D1 (en) | New benzothiazine derivatives, processes for preparation thereof and use thereof | |
DE69504392D1 (de) | Verwendung von Trovafloxacin oder dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung von H.Pylori Infektionen | |
HU912567D0 (en) | Preparation for decreasing uric acid contain in blood |